Rainbow Pharma Consulting was founded with the goal of assisting clients who are developing new drugs to translate their discoveries more efficiently into the clinical realm. Dr. Cynthia Sung, Founder and President, has over 18 years experience in drug discovery and drug development. Dr. Sung has worked as a Clinical Pharmacology Reviewer at the U.S. Food and Drug Administration (FDA) with responsibilities covering the full range of review, from pre-IND (Investigational New Drug Application) meetings to NDA (New Drug Application) review. Prior to the FDA, she served as Director of Pharmacokinetics at Human Genome Sciences, Inc. building and overseeing a department that participated in filing IND (Investigational New Drug Applications) documentation to initiate first-in-human studies for 10 experimental agents in oncology, immunology, infectious diseases and endocrinology. Her department helped design and monitor numerous Phase 1 and 2 trials, focusing on quantitative links between drug levels and biomarker changes. Dr. Sung has also worked at the U.S. National Institutes of Health (NIH) where she conducted research on monoclonal antibodies, antibody-toxin conjugates, drug delivery to solid tumors, the brain and eye. Building on Dr. Sung's experience, Rainbow Pharma Consulting seeks to assist clients in designing studies (preclinical and clinical) and preparing documentation that will advance the drug development of new therapeutic agents or new uses (indications) of existing drugs.
Rainbow Pharma Consulting is based in Singapore, but welcomes clients from any part of the world. Clients (past and present) include the Novartis Institute of Tropical Diseases, Protherapeutics, Bio*One Capital (subsidiary of the Singapore Economic Development Board), and the Singapore Health Sciences Authority.
Computer modeling and simulation of the relationships among drug concentrations and effects and/or disease progression
Writing manuscripts and reports on PK and PK/PD studies
Rainbow Pharma Consulting has not received any reviews.
Rainbow Pharma Consulting has not received any endorsements.